Table 4.
SOC | Total | PIO |
PLA |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
intensity of AE |
total | intensity of AE |
total | ||||||||
mild | mod. | sev. | NA | mild | mod. | sev. | NA | ||||
Gastrointestinal disorders | 20 | 6 | 1 | 0 | 0 | 7 | 10 | 3 | 0 | 0 | 13 |
Investigations | 18 | 7 | 2 | 0 | 0 | 9 | 3 | 5 | 1 | 0 | 9 |
Infections and infestations | 17 | 4 | 4 | 0 | 0 | 8 | 6 | 3 | 0 | 0 | 9 |
Musculoskeletal and connective tissue disorders | 17 | 5 | 3 | 0 | 0 | 8 | 5 | 3 | 1 | 0 | 9 |
Injury, poisoning and procedural complications | 14 | 3 | 5 | 0 | 0 | 8 | 3 | 2 | 1 | 0 | 6 |
Metabolism and nutrition disorders | 11 | 5 | 0 | 0 | 0 | 5 | 4 | 2 | 0 | 0 | 6 |
Vascular disorders | 9 | 1 | 4 | 1 | 0 | 6 | 0 | 2 | 1 | 0 | 3 |
Cardiac disorders | 7 | 1 | 1 | 0 | 0 | 2 | 3 | 2 | 0 | 0 | 5 |
Nervous system disorders | 4 | 2 | 0 | 0 | 0 | 2 | 2 | 0 | 0 | 0 | 2 |
Skin and subcutaneous tissue disorders | 4 | 2 | 0 | 0 | 0 | 2 | 2 | 0 | 0 | 0 | 2 |
General disorders and administration site conditions | 3 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 1 | 0 | 3 |
Eye disorders | 2 | 0 | 2 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
Surgical and medical procedures | 2 | 0 | 1 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 1 |
Blood and lymphatic system disorders | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Total | 129 | 37 | 23 | 1 | 0 | 61 | 41 | 22 | 5 | 0 | 68 |
mod. = Moderate; sev. = severe; NA = not available.